News

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...
Researchers found significant sex-based differences in ILD in patients with interdisciplinary indications for complete ...
“If I know you have cystic fibrosis, I’m going to go in a different direction than if I know you have interstitial lung disease, your BMI is 17 [kg/m 2]and you’re very frail,” Wharton sai ...
Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...
Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...
Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...
Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
According to WHO data, chronic obstructive pulmonary disease (COPD) or common lung disease has caused the deaths of around 3.5 million people in 2021. This disease is the fourth leading cause of death ...
A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.
A cancer drug available on the NHS could treat an incurable lung disease that plagues more than 30,000 Britons, a study claims. Idiopathic pulmonary fibrosis (IPF) occurs when scar tissue builds ...
On safety, there was a case of interstitial lung disease (ILD), a side effect that has been seen with other ADCs using Daiichi Sankyo's deruxtecan payload, like AstraZeneca's Enhertu (trastuzumab ...